中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
合肥物质科学研究院 [3]
上海药物研究所 [1]
心理研究所 [1]
高能物理研究所 [1]
采集方式
OAI收割 [5]
iSwitch采集 [1]
内容类型
期刊论文 [6]
发表日期
2023 [1]
2022 [2]
2021 [1]
2020 [1]
2018 [1]
学科主题
筛选
浏览/检索结果:
共6条,第1-6条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study
期刊论文
OAI收割
BMC CANCER, 2023, 卷号: 23
作者:
Cao, Fei
;
Shi, Changsheng
;
Zhang, Guofu
;
Luo, Jun
;
Zheng, Jiaping
  |  
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2023/11/10
Hepatocellular carcinoma
Atezolizumab
Bevacizumab
Overall survival
Progression-free survival
Neoadjuvant immunotherapy in non-small-cell lung cancer: a narrative review on mechanisms, efficacy and safety
期刊论文
OAI收割
JOURNAL OF THORACIC DISEASE, 2022
作者:
Shao, Lan
;
Lou, Guangyuan
  |  
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2022/12/22
Neoadjuvant
immunotherapy
immune-checkpoint inhibitors
non-small cell lung cancer (NSCLC)
A Novel Gene Signature Associated with Inflammatory Responses and Immune Status Assists in Prognosis and Intervention for Patients with HCC
期刊论文
OAI收割
JOURNAL OF INFLAMMATION RESEARCH, 2022, 卷号: 15, 页码: 6729-6743
作者:
Lu, Guofang
;
Du, Rui
;
Feng, Bin
;
Wang, Jianlin
;
Zhang, Fengrui
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2023/01/16
inflammation-associated gene
prognostic gene signature
immune infiltration
immune checkpoint
hepatocellular carcinoma
drug structure
Atezolizumab in combination with bevacizumab in patients with unresectable locally advanced or metastatic mucosal melanoma: Interim analysis of an open-label phase II trial.
期刊论文
OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Si, Lu
;
Fang, Meiyu
;
Chen, Yu
;
Mao, Lili
;
Zhang, Peng
  |  
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2022/01/10
Cancer nanomedicine meets immunotherapy: opportunities and challenges
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2020, 卷号: 41, 期号: 7, 页码: 954-958
作者:
Sun, Qingxue
;
Bai, Xiangyang
;
Sofias, Alexandros Marios
;
van der Meel, Roy
;
Ruiz-Hernandez, Eduardo
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2020/12/24
nanomedicine
immunotherapy
targeting
combination therapy
clinical translation
Dynamic change of pd-l1 expression on circulating tumor cells in advanced solid tumor patients undergoing pd-1 blockade therapy
期刊论文
iSwitch采集
Oncoimmunology, 2018, 卷号: 7, 期号: 7, 页码: 12
作者:
Yue, Chunyan
;
Jiang, Yubo
;
Li, Ping
;
Wang, Yuehua
;
Xue, Jian
收藏
  |  
浏览/下载:83/0
  |  
提交时间:2019/04/23
Advanced solid tumor
Circulating tumor cells (ctcs)
Immunotherapy
Programmed death-ligand 1 (pd-l1)
Semi-quantitative analysis